IT1244507B - Derivati dell'acido piroglutammico quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti - Google Patents
Derivati dell'acido piroglutammico quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali compostiInfo
- Publication number
- IT1244507B IT1244507B ITRM910246A ITRM910246A IT1244507B IT 1244507 B IT1244507 B IT 1244507B IT RM910246 A ITRM910246 A IT RM910246A IT RM910246 A ITRM910246 A IT RM910246A IT 1244507 B IT1244507 B IT 1244507B
- Authority
- IT
- Italy
- Prior art keywords
- compounds
- memory
- pharmaceutical compositions
- acid derivatives
- activators
- Prior art date
Links
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical class OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 title abstract 2
- 239000012190 activator Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 abstract 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 abstract 1
- -1 acetylaminoethyl Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06173—Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
- C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Derivati dell'acido piroglutammico di formula generale (I) in cui R è scelto tra 2-(N,N-diisopropil)amminoetil, 2-amminoetil, 2-N-[(pirrolidin-2-one-l-il)] acetilamminoetil, 2-feniletil, benzil, 2-N-(piroglutamilglicil)amminoetil, 2-N-(piroglutamil)amminoetil; Y è un legame semplice fra C e N oppure è il residuo bivalente di un amminoacido sono potenti attivatori della memoria e dei processi di apprendimento. Composizioni farmaceutiche somministrabili per via orale o parenterale in forma di dosaggio unitario, comprendono da circa 100 a circa 500 mg di uno dei composti di formula (I).
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITRM910246A IT1244507B (it) | 1991-04-11 | 1991-04-11 | Derivati dell'acido piroglutammico quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti |
| US07/864,688 US5227496A (en) | 1991-04-11 | 1992-04-07 | Pyroglutamic acid derivatives as enhancers of learning processes and memory and pharmaceutical compositions comprising same |
| JP4090851A JPH05117232A (ja) | 1991-04-11 | 1992-04-10 | ピログルタミン酸誘導体および医薬組成物 |
| EP19920830175 EP0511943A3 (en) | 1991-04-11 | 1992-04-10 | Pyroglutamic acid derivatives as enhancers of learning processes and memory and pharmaceutical compositions comprising same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITRM910246A IT1244507B (it) | 1991-04-11 | 1991-04-11 | Derivati dell'acido piroglutammico quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ITRM910246A0 ITRM910246A0 (it) | 1991-04-11 |
| ITRM910246A1 ITRM910246A1 (it) | 1992-10-11 |
| IT1244507B true IT1244507B (it) | 1994-07-15 |
Family
ID=11400081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITRM910246A IT1244507B (it) | 1991-04-11 | 1991-04-11 | Derivati dell'acido piroglutammico quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US5227496A (it) |
| EP (1) | EP0511943A3 (it) |
| JP (1) | JPH05117232A (it) |
| IT (1) | IT1244507B (it) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4681132B2 (ja) * | 2001-01-29 | 2011-05-11 | 味の素株式会社 | 一酸化窒素合成酵素産生促進剤および化粧料若しくは医薬組成物 |
| IL187159A0 (en) | 2007-07-03 | 2009-02-11 | Gur Megiddo | Use of metadoxine in relief of alcohol intoxication |
| WO2010013242A1 (en) | 2008-07-29 | 2010-02-04 | Alcobra Ltd. | Substituted pyridoxine-lactam carboxylate salts |
| WO2010065668A1 (en) | 2008-12-03 | 2010-06-10 | Presidio Pharmaceuticals, Inc. | Inhibitors of hcv ns5a |
| NZ597319A (en) | 2009-06-25 | 2014-06-27 | Alcobra Ltd | A method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition |
| EP2758371B1 (en) * | 2011-09-19 | 2016-06-15 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | New thio derivatives bearing lactams as potent hdac inhibitors and their uses as medicaments |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2651639A (en) * | 1951-08-22 | 1953-09-08 | American Cyanamid Co | 2-pyrrolidone-5-carboxamide derivatives and methods of preparing the same |
| US3051722A (en) * | 1960-10-21 | 1962-08-28 | Lakeside Lab Inc | 5-pyrrolidone-2-carboxamides |
| US4452989A (en) * | 1982-06-01 | 1984-06-05 | Charles Of The Ritz Group Ltd. | Substantive moisturizing derivatives of 2-pyrrolidone-5-carboxylic acid and compositions containing same |
| FR2597100A1 (fr) * | 1986-01-21 | 1987-10-16 | Nippon Shinyaku Co Ltd | Derives du pyroglutamide |
| JPH0699307B2 (ja) * | 1987-08-20 | 1994-12-07 | キッセイ薬品工業株式会社 | 抗痴呆剤 |
| US4772601A (en) * | 1988-01-25 | 1988-09-20 | Hoechst-Roussel Pharmaceuticals, Inc. | 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use |
-
1991
- 1991-04-11 IT ITRM910246A patent/IT1244507B/it active IP Right Grant
-
1992
- 1992-04-07 US US07/864,688 patent/US5227496A/en not_active Expired - Fee Related
- 1992-04-10 JP JP4090851A patent/JPH05117232A/ja active Pending
- 1992-04-10 EP EP19920830175 patent/EP0511943A3/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| US5227496A (en) | 1993-07-13 |
| EP0511943A2 (en) | 1992-11-04 |
| JPH05117232A (ja) | 1993-05-14 |
| ITRM910246A1 (it) | 1992-10-11 |
| ITRM910246A0 (it) | 1991-04-11 |
| EP0511943A3 (en) | 1992-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2226004T3 (es) | 2-cianopirrolidinas n-sustituidas. | |
| NO944162L (no) | Substituerte heterosykliske karboksylsyreamider, deres fremstilling og deres anvendelse som legemiddel | |
| AU2002366811A1 (en) | Pyrimidine a2b selective antagonist compounds, their synthesis and use | |
| JP5436462B2 (ja) | ピペラジン誘導体及び使用方法 | |
| IS6275A (is) | Heteróhringa efnasambönd og notkun þeirra sem mótlyf efnaskiptaglútamatviðtaka | |
| NO934501L (no) | Karboksylsyrederivater, legemidler inneholdende disse forbindelser, og fremgangsmåte for deres fremstilling | |
| DE69713582D1 (de) | Zimtsäurederivate und deren verwendung als integrin-antagonisten | |
| JPH04230369A (ja) | イミダゾールの新規な硫黄誘導体、その製造方法、得られる新規な中間体、薬物としてのその使用、及びそれを含有する医薬組成物 | |
| AU7517400A (en) | N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent | |
| NO20045452L (no) | Anvendelse av substituerte cyanopyrrolidiner og kombinasjonspreparater inneholdende disse for behandling av hyperlipidemi og assosierte sykdommer | |
| HUE027051T2 (en) | Pyridinone derivatives as tissue transglutaminase inhibitors | |
| MXPA03000161A (es) | Compuestos novedosos los cuales tienen actividad antiinflamatoria, proceso para su preparacion y composiciones farmaceuticas que las contienen. | |
| ES2328405T3 (es) | Piperazina sustituida por 2-aminocarbonil o compuestos diaza-ciclicos como moduladores del inhibidor de la proteina de la apoptosis (iap). | |
| ES2311847T3 (es) | Nuevos derivados de imidazoles, su prepracion y su utilizacion como medicamento. | |
| DK0597102T3 (da) | Nyt bisheterocyklisk derivat og salt heraf samt hypoglykæmisk sammensætning | |
| IL63381A0 (en) | 5-substituted 5,10-dihydro-11h-dibenzo(b,e)(1,4)diazepin-11-one derivatives,their preparation and pharmaceutical compositions containing them | |
| IT1256320B (it) | Derivati eterociclici | |
| IT1265077B1 (it) | Derivati del cicloeptimmidazolo, metodo per la loro produzione e agenti terapeutici contenenti questi composti | |
| AU658175B2 (en) | Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients | |
| IL163344A (en) | 2-(4-(3-cyclopentyloxy-4-difluoromethoxyphenyl)-4-cyanopiperidin-1-yl)acetic acid derivative compounds, process for their synthesis and compositions comprising the compounds as the active ingredient | |
| DE3876711D1 (de) | Piperidin-derivate, deren herstellung und deren verwendung als heilmittel. | |
| IT1247697B (it) | Composizioni farmaceutiche comprendenti 3-ammino-e-caprolattami per il potenziamento dei processi di apprendimento e della memoria. | |
| NZ225528A (en) | Benzimidazoles substituted in the 2 position by n(4-n-guanidyl) piperidinyl radicals; preparations thereof; pharmaceutical compositions | |
| Smith et al. | Discovery and parallel synthesis of a new class of cathepsin K inhibitors | |
| DK279988D0 (da) | Spiro(4,5)decanderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 0001 | Granted | ||
| TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19960307 |